{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Triazole derivatives which are SMO antagonists", "item": "https://www.patentleaderboard.com/patent/7691887"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Triazole derivatives which are SMO antagonists

Triazole derivatives which are SMO antagonists

US Patent 7691887 · Granted Apr 6, 2010

Estimated economic value: $50,617,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for the treatment of viral infections2023
Tricyclic heterocycle compounds useful as HIV integrase inhibitors2021
Substituted quinolizine derivatives useful as HIV integrase inhibitors2020
Spirocyclic Pyridotriazine Derivatives useful as HIV integrase inhibitors2020
Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitors2020
Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors2020
Fused tricyclic heterocyclic compounds useful for treating HIV infection2019
Spirocyclic heterocyclic compounds useful as HIV integrase inhibitors2019
Substituted quinolizine derivatives useful as HIV integrase inhibitors2019
Spirocyclic heterocycle compounds useful as HIV integrase inhibitors2018
Piperazine derivatives as HIV protease inhibitors2018
Phosphate substituted quinolizine derivatives useful as HIV integrase inhibitors2018